Heart failure patients to test their own best dose in new study
NCT ID NCT07489352
First seen Mar 26, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study aims to see if a personalized approach, called N-of-1 trials, can help older adults with heart failure find the highest beta-blocker dose they can tolerate without side effects. Fifty participants aged 60 and older will be split into two groups: one using the personalized trial method and the other receiving enhanced usual care. The goal is to improve dosing decisions and patient well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.